Is recruitment more difficult with a placebo arm in randomised controlled trials? A quasirandomised, interview based study

British Medical Journal

Volumn 318, Issue 7191, 1999, Pages 1114-1117

  Welton, A J ^a   Vickers, M R ^a   Cooper, J A ^a   Meade, T W ^a   Marteau, T M ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

PLACEBO;

ADULT; ARTICLE; CLINICAL RESEARCH; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DECISION MAKING; FEMALE; HORMONE SUBSTITUTION; HUMAN; HUMAN EXPERIMENT; NORMAL HUMAN; PATIENT COMPLIANCE; POSTMENOPAUSE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

EID: 0033599791     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: 10.1136/bmj.318.7191.1114     Document Type: Article

References (10)

1. 1 Henderson BE, Pike MC, Ross RK, Mack TM, Lobo RA. Re-evaluating the role of progestogen therapy after the menopause. Fert Steril 1988;49:9-15S.
2. 2 Grady D, Rubin SM, Petitti DB, Fox CS, Black D, Ettinger B, et al. Hormone therapy to prevent disease and prolong life in postmenopausal women. Ann Intern Med 1992;117:1016-41.
3. 3 Writing Group for the PEPI trial. Effects of estrogen/progestin regimens on heart disease risk factors in postmenopausal women: the postmenopausal estrogen/progestin interventions (PEPI) trial. JAMA 1995;273:199-208.
4. 4 Stampfer MJ, Colditz GA, Willett WC, Manson JE. Rosner B, Speizer FE, et al. Postmenopausal estrogen therapy and cardiovascular disease: ten-year follow-up from the nurses' health study. N Engl J Med 1991;325: 756-62.
5. 5 Medical Research Council's General Practice Research Framework. Randomised comparison of oestrogen versus oestrogen plus progestogen hormone replacement therapy in women with hysterectomy. BMJ 1996;312:473-8.
6. 6 Fisher LD, van Belle G. Biostatistics: a methodology for the health sciences. New York: John Wiley, 1993.
7. 7 Mattson ME, Curb DJ, McArdle R, and the Aspirin Myocardial Infarction Study and Beta-blocker Heart Attack Trial Research Groups. Participation in a clinical trial: the patients' point of view. Controlled Clin Trials 1985;6:156-67.
8. 8 Cassileth BR, Lusk EJ, Miller DS, Hurwitz S. Attitudes towards clinical trials among patients and the public. JAMA 1982;248:968-70.
9. 9 Hunter MS, Liao KLM. Intentions to use hormone replacement therapy in a community sample of 45-year-old women. Maturitas 1994;20:13-23.
10. 10 Office of Population Censuses and Surveys. Standard occupational classifications. London: HMSO, 1993.